With the aim to evaluate zonulin levels, a marker for intestinal permeability, in new-onset RA patients and to compare them to patients with other newly-diagnosed rheumatic diseases, zonulin levels were quantified in 163 serum samples from the Rheuma-VOR cohort using a commercial ELISA kit. This evidence concerns the gene HP and rheumatic disorder.